Nervgen Pharma Corp Stock Probability of Future OTC Stock Price Finishing Under 1.88
| NGENF Stock | USD 1.87 0.05 2.60% |
NervGen |
NervGen Pharma Target Price Odds to finish below 1.88
The tendency of NervGen OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to stay under $ 1.88 after 90 days |
| 1.87 | 90 days | 1.88 | about 61.07 |
Based on a normal probability distribution, the odds of NervGen Pharma to stay under $ 1.88 after 90 days from now is about 61.07 (This NervGen Pharma Corp probability density function shows the probability of NervGen OTC Stock to fall within a particular range of prices over 90 days) . Probability of NervGen Pharma Corp price to stay between its current price of $ 1.87 and $ 1.88 at the end of the 90-day period is roughly 2.76 .
Assuming the 90 days horizon NervGen Pharma has a beta of 0.9. This indicates NervGen Pharma Corp market returns are reactive to returns on the market. As the market goes up or down, NervGen Pharma is expected to follow. Additionally NervGen Pharma Corp has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. NervGen Pharma Price Density |
| Price |
Predictive Modules for NervGen Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as NervGen Pharma Corp. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.NervGen Pharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. NervGen Pharma is not an exception. The market had few large corrections towards the NervGen Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold NervGen Pharma Corp, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of NervGen Pharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.12 | |
β | Beta against Dow Jones | 0.90 | |
σ | Overall volatility | 0.14 | |
Ir | Information ratio | -0.03 |
NervGen Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of NervGen Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for NervGen Pharma Corp can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| NervGen Pharma Corp generated a negative expected return over the last 90 days | |
| NervGen Pharma Corp may become a speculative penny stock | |
| NervGen Pharma Corp has high historical volatility and very poor performance | |
| NervGen Pharma Corp has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (12.73 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| NervGen Pharma Corp has accumulated about 11.65 M in cash with (8.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.2. | |
| Roughly 25.0% of the company outstanding shares are owned by corporate insiders |
NervGen Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of NervGen OTC Stock often depends not only on the future outlook of the current and potential NervGen Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. NervGen Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 46.2 M |
NervGen Pharma Technical Analysis
NervGen Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. NervGen OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of NervGen Pharma Corp. In general, you should focus on analyzing NervGen OTC Stock price patterns and their correlations with different microeconomic environments and drivers.
NervGen Pharma Predictive Forecast Models
NervGen Pharma's time-series forecasting models is one of many NervGen Pharma's otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary NervGen Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.
Things to note about NervGen Pharma Corp
Checking the ongoing alerts about NervGen Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for NervGen Pharma Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| NervGen Pharma Corp generated a negative expected return over the last 90 days | |
| NervGen Pharma Corp may become a speculative penny stock | |
| NervGen Pharma Corp has high historical volatility and very poor performance | |
| NervGen Pharma Corp has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (12.73 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| NervGen Pharma Corp has accumulated about 11.65 M in cash with (8.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.2. | |
| Roughly 25.0% of the company outstanding shares are owned by corporate insiders |
Other Information on Investing in NervGen OTC Stock
NervGen Pharma financial ratios help investors to determine whether NervGen OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NervGen with respect to the benefits of owning NervGen Pharma security.